Plasma HERV-K envelopE RNA: a minimally invasive biomarker for lung adenocarcinoma detection and prognostic assessment in the context of conventional serum tumor markers - Top-Institutions - MDSpire

Plasma HERV-K envelopE RNA: a minimally invasive biomarker for lung adenocarcinoma detection and prognostic assessment in the context of conventional serum tumor markers

  • By

  • Fan Bu

  • Zi-Yan Jin

  • Zhi-Qiang Ling

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Zhejiang Cancer Hospital
    Zhejiang Cancer Hospital

    Hangzhou, Zhejiang

    Key Differentiators

    • Oncology

  • #2

    Asan Medical Center
    Asan Medical Center

    Seoul, South Korea

    Key Differentiators

    • Gastroenterology
    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #4

    Hebei Central Hospital of Petroleum
    Hebei Central Hospital of Petroleum

    Hebei, China

    Key Differentiators

    • Oncology

  • #5

    Nanjing Drum Tower Hospital
    Nanjing Drum Tower Hospital

    Nanjing, Jiangsu

    Key Differentiators

    • Oncology

Original Source(s)

Plasma HERV-K envelopE RNA: a minimally invasive biomarker for lung adenocarcinoma detection and prognostic assessment in the context of conventional serum tumor markers

  • by Fan Bu, Zi-Yan Jin, Zhi-Qiang Ling

  • July 1, 2026

Related Content

Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis

Diagnostic performance of adult-based ultrasound ACR-TIRADS and C-TIRADS in adolescent thyroid nodules

The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics